Christopher P. Simpson

Christopher Simpson counsels clients regarding a wide range of transactional and corporate law matters. Mr. Simpson advises clients across the spectrum – from growth-oriented companies to private equity funds – on significant mergers, acquisitions, and similar transactions as well as day to day strategic and commercial matters.

Practice Focus

Private Equity: represents and advises private equity funds in connection with initial investments, interim transactions and exit sales. Represents and advises portfolio companies on operational, strategic, and commercial matters.

Mergers & Acquisitions: Represents private equity sponsor-backed, as well as venture- and founder-backed companies in acquisitions, sales and recapitalizations.

Business & Technology: represents and advises public and private companies in a variety of industries in mergers and acquisitions, securities law compliance issues, venture capital equity financings and general corporate work.

Life Sciences: represents and advises life sciences clients on various corporate matters including negotiating investments, mergers and acquisitions, public offerings and assisting with corporate and business development strategies for early-stage life science and emerging life sciences companies.

Professional and Community Involvement

Mr. Simpson is a member of the Leukemia and Lymphoma Society.

Education & Credentials

Notre Dame Law School
JD, magna cum laude, 2011

Notre Dame Law Review, Articles Editor

Wesleyan University
BA, 2008